HCA
RCKT icon

Harbor Capital Advisors’s Rocket Pharmaceuticals RCKT Stock Holding History

Harbor Capital Advisors’s Portfolio RCKT Stock Details RCKT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-178,236
Closed -$1.19M – 1419
2025
Q1 		$1.19M Buy
178,236
+13,109
+8% +$130K 0.05% 404
2024
Q4 		$2.08M Sell
165,127
-3,379
-2% -$50.9K 0.09% 275
2024
Q3 		$3.11M Buy
168,506
+71,372
+73% +$1.46M 0.14% 218
2024
Q2 		$2.09M Buy
97,134
+15,708
+19% +$361K 0.16% 190
2024
Q1 		$2.19M Buy
81,426
+27,071
+50% +$769K 0.29% 67
2023
Q4 		$1.63M Sell
54,355
-2,962
-5% -$65.4K 0.31% 83
2023
Q3 		$1.17M Buy
57,317
+2,035
+4% +$37K 0.25% 100
2023
Q2 		$1.1M Buy
55,282
+2,009
+4% +$40.6K 0.22% 115
2023
Q1 		$913K Sell
53,273
-11,736
-18% -$230K 0.26% 95
2022
Q4 		$1.27M Sell
65,009
-1,401
-2% -$25.8K 1.23% 26
2022
Q3 		$1.06M Sell
66,410
-7,333
-10% -$114K 0.97% 33
2022
Q2 		$1.01M Sell
73,743
-1,434
-2% -$17.1K 0.77% 38
2022
Q1 		$1.19M Sell
75,177
-13,208
-15% -$228K 0.56% 55
2021
Q4 		$1.93M Buy
+88,385
New +$2.41M 0.7% 46

Other funds holding RCKT

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.6B AUM 48.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.69B AUM 86.67% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Millennium Management
Millennium Management New York $134B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
NM
Newtyn Management New York $936M AUM 27.23% 1-Year Est. Return